CNMD · NYSE
CONMED (CNMD) Stock Price & Fundamentals
CONMED (CNMD) closed at $218.83 on Oct 9, 2026, up 0.70% from the previous close of $217.31.
Share price, past year
1Y −18.86%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $218.83 |
| Sep 30, 2026 | $218.02 |
| Aug 31, 2026 | $222.08 |
| Jul 31, 2026 | $234.96 |
| Jun 30, 2026 | $219.15 |
| May 29, 2026 | $229.81 |
| Apr 30, 2026 | $235.54 |
| Mar 31, 2026 | $239.79 |
| Feb 27, 2026 | $234.68 |
| Jan 30, 2026 | $251.10 |
| Dec 31, 2025 | $243.70 |
| Nov 28, 2025 | $260.81 |
| Oct 31, 2025 | $268.67 |
Key statistics
- Market cap
- $6.55B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 30M
- Dividend yield
- 0.27%
- 52-week range
- $216.10 – $273.45
CONMED's market cap is $6.55B, based on a share price of $218.83 and 30M shares outstanding as of Jul 27, 2026.
Financials
CONMED reported revenue of $1.37B for fiscal 2025, up 5.18% from fiscal 2024.
CONMED earned net income of $47.06M in fiscal 2025, a net margin of 3.4%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.37B | +5.2% | $47.06M | 3.4% | $1.51 | $150.88M |
| FY2024ended Dec 31, 2024 | $1.31B | +5.0% | $132.42M | 10.1% | $4.25 | $153.88M |
| FY2023ended Dec 31, 2023 | $1.24B | +19.1% | $64.46M | 5.2% | $2.04 | $106.32M |
| FY2022ended Dec 31, 2022 | $1.05B | +3.5% | −$80.58M | −7.7% | −$2.68 | $11.58M |
| FY2021ended Dec 31, 2021 | $1.01B | +17.2% | $62.54M | 6.2% | $1.94 | $96.90M |
| FY2020ended Dec 31, 2020 | $862.46M | −9.7% | $9.52M | 1.1% | $0.32 | $51.52M |
| FY2019ended Dec 31, 2019 | $955.10M | +11.1% | $28.62M | 3.0% | $0.97 | $75.07M |
| FY2018ended Dec 31, 2018 | $859.63M | +7.9% | $40.85M | 4.8% | $1.41 | $58.19M |
| FY2017ended Dec 31, 2017 | $796.39M | +4.3% | $55.49M | 7.0% | $1.97 | $52.72M |
| FY2016ended Dec 31, 2016 | $763.52M | — | $14.66M | 1.9% | $0.52 | $25.13M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $343.49M | $23.07M | $0.77 |
| Q4 FY2025ended Dec 31, 2025 | $373.20M | $16.74M | $0.54 |
| Q3 FY2025ended Sep 30, 2025 | $337.93M | $2.86M | $0.09 |
| Q2 FY2025ended Jun 30, 2025 | $342.35M | $21.42M | $0.69 |
| Q1 FY2025ended Mar 31, 2025 | $321.26M | $6.04M | $0.19 |
| Q4 FY2024ended Dec 31, 2024 | $345.94M | $33.75M | $1.09 |
| Q3 FY2024ended Sep 30, 2024 | $316.70M | $48.98M | $1.57 |
| Q2 FY2024ended Jun 30, 2024 | $332.10M | $29.98M | $0.96 |
Company profile
- Name
- CONMED Corp
- Ticker
- CNMD
- Exchange
- NYSE
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 11311 Concept Boulevard, Largo, FL 33773
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000816956
Recent SEC filings
- Jul 29, 2026
- Jul 29, 2026
- Jun 17, 2026
- Jun 4, 2026
- Jun 1, 2026
- May 20, 2026
- Apr 30, 2026
- Apr 29, 2026
Frequently asked questions
What is CONMED's stock price?
CONMED (CNMD) closed at $218.83 on Oct 9, 2026, up 0.70% from the previous close of $217.31.
What is CONMED's market cap?
CONMED's market cap is $6.55B, based on a share price of $218.83 and 30M shares outstanding as of Jul 27, 2026.
How much revenue does CONMED make?
CONMED reported revenue of $1.37B for fiscal 2025, up 5.18% from fiscal 2024.
Does CONMED pay a dividend?
Yes. CONMED declared $0.60 per share in dividends over the last four quarters, a yield of 0.27%.
Sources and methodology
Fundamentals come from CONMED Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures